Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-01-30
2007-01-30
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S186000, C544S187000, C544S188000
Reexamination Certificate
active
10952396
ABSTRACT:
The present application describes sulfonylaminovalerolactams and derivatives thereof of Formula Ia–If:or pharmaceutically acceptable salt forms thereof, wherein ring G is a mono- or bicyclic carbocycle or heterocycle. Compounds of the present invention are useful as inhibitors of trypsin-like serine proteases, specifically factor Xa.
REFERENCES:
patent: 2002/0183324 (2002-12-01), Jacobson et al.
patent: 2004/0006062 (2004-01-01), Smallheer et al.
patent: WO 03/049735 (2003-06-01), None
patent: WO 03/050109 (2003-06-01), None
patent: WO03/053925 (2003-07-01), None
U.S. Appl. No. 10/952,397, filed Sep. 28, 2004, Han et al.
U.S. Appl. No. 10/952,204, filed Sep. 28, 2004, Shi et al.
Elodi et al., “Optimization of conditions for the catalytic effect of the factor IXa-factor VIII Complex: Probable role of the complex in the amplification of blood coagulation”,Thromb. Res., vol. 15, pp. 617-629, 1979.
Gungor Timur
Han Wei
Hu Zilun
Bristol Myers Squibb Company
Kifle Bruck
Sun Jing G.
Vance David H.
LandOfFree
Sulfonylaminovalerolactams and derivatives thereof as factor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfonylaminovalerolactams and derivatives thereof as factor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonylaminovalerolactams and derivatives thereof as factor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3773505